Predicting the impact of adverse events and treatment duration on medical resource utilization-related costs in hepatitis C genotype 1 treatment-naïve patients receiving antiviral therapy.

Abstract excerpt

OBJECTIVES: Studies on medical resource utilization (MRU) and related costs are important for evaluating the potential patient management and cost-effectiveness implications of antiviral treatments for hepatitis C virus (HCV) infection. The objectives of this study were (i) to compare the MRU and related costs for two treatment approaches; (ii) to identify the main drivers of resource use and costs; and (iii) to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clinical Trials, Phase III as Topic
• Share to Cost-Benefit Analysis